-
-
Call more information
660-596-2224 -
Authors: Karen C. Nanji MD MPH et al Anesthesiology 1 2016, Vol.124, 25-34. Background: The purpose of this study is to assess the rates of perioperative medication errors (MEs) and adverse drug events (ADEs) as percentages of medication administrations, to evaluate their root causes, and to formulate targeted solutions to prevent them. Methods: In this prospective observational study, anesthesia-trained […]
Read MoreThe CDC has proposed 12 recommendations for clinicians prescribing opioids. Among them: When initiating opioid therapy, immediate-release opioids at the lowest effective doses are recommended. Extra precautions should be taken when prescribing at or above 50 morphine milligram equivalents (MME) per day, and doses at or above 90 MME per day generally should be avoided. […]
Read MoreNearly 20 organizations including the Academy have endorsed an updated “consensus statement” from the organization SmartTots calling for more research into the safety of anesthetics and sedatives administered to children younger than 4 years. Some evidence has shown that such exposures in very young animals are associated with impairment in learning ability, behavior and memory. […]
Read MoreA simple blood test taken before surgery may predict how quickly patients recover from their procedure, suggests a new study in the December issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists (ASA). According to the study, identifying a patient’s immune state from blood samples taken before surgery, revealed patterns that may […]
Read MoreThe US Food and Drug Administration (FDA) has approved sugammadex injection (Bridion, Merck) for the reversal of moderate or deep neuromuscular blockade induced by rocuronium or vecuronium during surgery, according to an agency news release. The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee recommended approval of the drug back in November. Sugammadex binds to rocuronium and […]
Read More